Epilepsy - HealthQuill

Grey matter in the human brain may be linked to the start of adolescent smoking and nicotine addiction — a study that may have implications for prevention and treatment.

MIT’s 40Hz gamma stimulation shows promise in slowing Alzheimer’s progression

HQ Team March 15, 2025: A decade of research at MIT’s Picower Institute for Learning and Memory has brought hope to millions battling.

by HealthQuill
March 15, 2025
0 Comments

King’s and University College of London researchers have developed an artificial intelligence tool that can detect 64% of brain abnormalities, that radiologists miss, in epileptic child patients.

Health Medical Research

UK researchers develop AI tool to detect brain lesions in epileptic children

King’s and University College of London researchers have developed an artificial intelligence tool that can detect 64% of brain abnormalities, that radiologists miss,.

by HealthQuill
February 25, 2025
0 Comments

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

Drugs Health Research

Cambridge researchers making brain implants to treat Parkinson’s

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

by HealthQuill
January 31, 2025
0 Comments

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug to treat seizures in a group of rare epilepsies.

Drugs Health Pharma

Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.

by HealthQuill
October 14, 2024
0 Comments

Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.

Drugs Health Pharma

Takeda’s trials for epilepsy treatment fail to meet primary seizure goals

Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.

by HealthQuill
June 18, 2024
0 Comments

Neuroscientists at the University of California, Berkeley, used AI software to reconstruct a song from the brain recordings, adding another brick in the wall of human understanding of processing music.

Drugs Health Pharma

Berkeley researchers recreate Pink Floyd song from brain activity

HQ Team August 17, 2023: Neuroscientists at the University of California, Berkeley, used AI software to reconstruct a song from the brain recordings,.